The emergence of COVID-19 has caused extensive harm and is recognized as a significant threat to human life worldwide. Currently, the application of nanomedicine techniques in pre-clinical studies related to various infections, such as respiratory viruses, herpes viruses, human papillomavirus, and HIV, has demonstrated success. Nanoparticles, due to their specific attributes, have garnered considerable attention in combating COVID-19. Strategies employing nanomaterials for COVID-19 prevention encompass the development of rapid, precise diagnostic tools, the creation of effective disinfectants, the delivery of mRNA vaccines to the biological system, and the administration of antiretroviral medications within the body. This article focuses on recent research regarding the effectiveness of nano platforms as antiviral measures against coronaviruses. It delves into the molecular characteristics of coronaviruses and the affected target systems, highlighting challenges and limitations in combating SARS-CoV-2. Additionally, it explores potential nanotechnology-based treatments to confront current and future variants of coronaviruses associated with COVID-19 infections.
Day, M. (2020) Covid-19: Four Fifths of Cases Are Asymptomatic, China Figures Indicate. BMJ, 369, Article No. 1375. https://doi.org/10.1136/bmj.m1375
Sutton, D., Fuchs, K., D’Alton, M. and Gofman, D. (2020) Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. The New England Journal of Medicine, 382, 2163-2164. https://doi.org/10.1056/NEJMc2009316
Mizumoto, K., Kagaya, K., Zarebski, A. and Chowell, G. (2020) Estimating the Asymptomatic Proportion of Coronavirus Disease 2019 (COVID-19) Cases on Board the Diamond Princess Cruise Ship, Yokohama, Japan, 2020. Eurosurveillance, 25, Article 2000180. https://doi.org/10.2807/1560-7917.ES.2020.25.10.2000180
Yang, Y., Chawla, A., Zhang, J., Esa, A., Jang, H.L. and Khademhosseini, A. (2019) Applications of Nanotechnology for Regenerative Medicine; Healing Tissues at the Nanoscale. In: Atala, A., et al., Eds., Principles of Regenerative Medicine, Elsevier, Amsterdam, 485-504. https://doi.org/10.1016/B978-0-12-809880-6.00029-1
Lin, L.C.W., Chattopadhyay, S., Lin, J.C. and Hu, C.M.J. (2018) Advances and Opportunities in Nanoparticle-and Nanomaterial-Based Vaccines against Bacterial Infections. Advanced Healthcare Materials, 7, Article 1701395. https://doi.org/10.1002/adhm.201701395
Cojocaru, F.-D., Botezat, D., Gardikiotis, I., Uritu, C.-M., Dodi, G., Trandafir, L., Rezus, C., Rezus, E., Tamba, B.-I. and Mihai, C.-T. (2020) Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics, 12, Article 171. https://doi.org/10.3390/pharmaceutics12020171
Nasrollahzadeh, M., Sajjadi, M., Soufi, G.J., Iravani, S. and Varma, R.S. (2020) Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses. Nanomaterials, 10, Article 1072. https://doi.org/10.3390/nano10061072
Akbarzadeh, A., Kafshdooz, L., Razban, Z.., et al. (2018) An Overview Application of Silver Nanoparticles in Inhibition of Herpes Simplex Virus. Artificial Cells, Nanomedicine, and Biotechnology, 46, 263-267. https://doi.org/10.1080/21691401.2017.1307208
Weiss, C., Carriere, M., Fusco, L., Capua, I., Regla-Nava, J.A., et al. (2020) Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic. ACS Nano, 14, 6383-6406. https://doi.org/10.1021/acsnano.0c03697
Tavakol, S., Hoveizi, E., Kharrazi, S., Tavakol, B., Karimi, S. and Rezayat, S.M. (2017) Organelles and Chromatin Fragmentation of Human Umbilical Vein Endothelial Cell Influence by the Effects of Zeta Potential and Size of Silver Nanoparticles in Different Manners. Artificial Cells, Nanomedicine, and Biotechnology, 45, 817-823. https://doi.org/10.1080/21691401.2016.1178132
Lisuzzo, L., Cavallaro, G., Parisi, F., Milioto, S., Fakhrullin, R. and Lazzara, G. (2019) Core/Shell Gel Beads with Embedded Halloysite Nanotubes for Controlled Drug Release. Coatings, 9, Article 70. https://doi.org/10.3390/coatings9020070
Cagno, V., Andreozzi, P., D’Alicarnasso, M., Silva, P.J., Mueller, M., Galloux, M., et al. (2018) Broad-Spectrum Non-Toxic Antiviral Nanoparticles with a Virucidal Inhibition Mechanism. Nature Materials, 17, 195-203. https://doi.org/10.1038/nmat5053
Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., Liu, Y., Liu, Y., Wang, G., Yuan, Z., Hou, X., Ren, L., Wu, Y. and Chen, Y. (2021) Human Kidney Is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Nature Communications, 12, Article No. 2506. https://doi.org/10.1038/s41467-021-22781-1
Seredych, M., Haines, B., Sokolova, V., Cheung, P., Meng, F., Stone, L., et al. (2018) Graphene-Based Materials for the Fast Removal of Cytokines from Blood Plasma. ACS Applied Bio Materials, 1, 436-443. https://doi.org/10.1021/acsabm.8b00151
Tavakol, S., Ashrafizadeh, M., Deng, S., Azarian, M., Abdoli, A., Motavaf, M., et al. (2019) Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems. Biomolecules, 9, Article 530. https://doi.org/10.3390/biom9100530
Al-Halifa, S., Gauthier, L., Arpin, D., Bourgault, S. and Archambault, D. (2019) Nanoparticle-Based Vaccines against Respiratory Viruses. Frontiers in Immunology, 10, Article 22. https://doi.org/10.3389/fimmu.2019.00022
Zheng, Z., Li, Z., Xu, C., Guo, B. and Guo, P. (2019) Folate-Displaying Exosome Mediated Cytosolic Delivery of siRNA Avoiding Endosome Trapping. Journal of Controlled Release, 311, 43-49. https://doi.org/10.1016/j.jconrel.2019.08.021
Arbuthnot, P. (2015) Gene Therapy for Respiratory Viral Infections. In: Gene Therapy for Viral Infections, Academic Press, Cambridge, MA, 281-297. https://doi.org/10.1016/B978-0-12-410518-8.00009-0
Rabaan, A.A., Al-Ahmed, S.H., Haque, S., Sah, R., Tiwari, R., Malik, Y.S., et al. (2020) SARS-CoV-2, SARS-CoV, and MERS-COV: A Comparative Overview. Le Infezioni in Medicina, 28, 174-184.
Gu, S.H., Yu, C.H., Song, Y., Kim, N.Y., Sim, E., Choi, J.Y., et al. (2020) A Small Interfering RNA Lead Targeting RNA-Dependent RNA-Polymerase Effectively Inhibit the SARS-CoV-2 Infection in Golden Syrian Hamster and Rhesus Macaque. bioRxiv. https://doi.org/10.1101/2020.07.07.190967
Sohail, M.F., Hussain, S.Z., Saeed, H., Javed, I., Sarwar, H.S., Nadhman, A., et al. (2018) Polymeric Nanocapsules Embedded with Ultra-Small Silver Nanoclusters for Synergistic Pharmacology and Improved Oral Delivery of Docetaxel. Scientific Reports, 8, Article No. 13304. https://doi.org/10.1038/s41598-018-30749-3
Chen, C.-K., Huang, P.-K., Law, W.-C., Chu, C.-H., Chen, N.-T. and Lo, L.-W. (2020) Biodegradable Polymers for Gene-Delivery Applications. International Journal of Nanomedicine, 15, 2131-2150. https://doi.org/10.2147/IJN.S222419
(2020) BioNTech and Pfizer Announce Regulatory Approval from German Authority Paul-Ehrlich-Institute to Commence First Clinical Trial of COVID-19 Vaccine Candidates. BIONTECH. https://investors.biontech.de/news-releases/news-release-details/biontech-and-pfizer-announce-regulatory-approval-german
Zeng, C., et al. (2020) Leveraging MRNAs Sequences to Express SARS-CoV-2 Antigens in Vivo. bioRxiv. https://www.biorxiv.org/content/10.1101/2020.04.01.019877v1 https://doi.org/10.1101/2020.04.01.019877
(2020) Arcturus Terapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine Using STARR™ Technology. ARCTURUS Therapeutics. https://ir.arcturusrx.com/news-releases/news-release-details/arcturus-therapeutics-and-duke-nus-medical-school-partner
Lim, M., et al. (2020) Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies. Pharmaceutics, 12, Article 30. https://doi.org/10.3390/pharmaceutics12010030
Wang, Q., et al. (2016) Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-Human Primates. ACS Infectious Diseases, 2, 361-376. https://doi.org/10.1021/acsinfecdis.6b00006
Quinlan, B.D., et al. (2020) The SARS-CoV-2 Receptor-Binding Domain Elicits a Potent Neutralizing Response without Antibody-Dependent Enhancement. bioRxiv. https://www.biorxiv.org/content/10.1101/2020.04.10.036418v1 https://doi.org/10.1101/2020.04.10.036418
Chen, W.H., et al. (2017) Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), A SARS Vaccine Candidate. Journal of Pharmaceutical Sciences, 106, 1961-1970. https://doi.org/10.1016/j.xphs.2017.04.037
Iwasaki, A. and Yang, Y. (2020) The Potential Danger of Suboptimal Antibody Responses in COVID-19. Nature Reviews Immunology, 20, 339-341. https://doi.org/10.1038/s41577-020-0321-6
Peeples, L. (2020) News Feature: Avoiding Pitfalls in the Pursuit of a COVID-19 Vaccin. Proceedings of the National Academy of Sciences of the United States of America, 117, 8218-8221. https://doi.org/10.1073/pnas.2005456117
Zhao, J., et al. (2020) Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019. Clinical Infectious Diseases, 71, 2027-2034.
Zhang, B., et al. (2020) Immune Phenotyping Based on Neutrophil-to-Lymphocyte Ratio and IgG Predicts Disease Severity and Outcome for Patients with COVID-19. medRxiv. https://www.medrxiv.org/content/10.1101/2020.03.1 2.20035048v1 https://doi.org/10.3389/fmolb.2020.00157
McCurry-Schmidt, M. (2020) LJI Scientists Awarded New Funding to COMBAT COVID-19. La Jolla Institute for Immunology. La Jolla Institute for Immunology. https://www.lji.org/news-events/news/post/lji-scientists-awarded-new-funding-to-combat-covid-19
Li, W., Joshi, M.D., Singhania, S., Ramsey, K.H. and Murthy, A.K. (2014) Peptide Vaccine: Progress and Challenges. Vaccines, 2, 515-536. https://doi.org/10.3390/vaccines2030515
Mohsen, M.O., Zha, L., Cabral-Miranda, G. and Bachmann, M.F. (2017) Major Findings and Recent Advances in Virus-Like Particle (VLP)-Based Vaccines. Seminars in Immunology, 34, 123-132. https://doi.org/10.1016/j.smim.2017.08.014
Bezu, L., et al. (2018) Trial Watch: Peptide-Based Vaccines in Anticancer Therapy. Oncoimmunology, 7, e1511506. https://doi.org/10.1080/2162402X.2018.1511506
Wang, W., et al. (2020) Dual-Targeting Nanoparticle Vaccine Elicits a Therapeutic Antibody Response against Chronic Hepatitis B. Nature Nanotechnology, 15, 406-416. https://doi.org/10.1038/s41565-020-0648-y
Shin, M.D., Shukla, S., Chung, Y.H., et al. (2020) COVID-19 Vaccine Development and a Potential Nanomaterial Path forward. Nature Nanotechnology, 15, 646-655. https://doi.org/10.1038/s41565-020-0737-y
Liu, Z., et al. (2017) Coordinating Antigen Cytosolic Delivery and Danger Signaling to Program Potent Cross-Priming by Micelle-Based Nanovaccine. Cell Discovery, 3, Article No. 17007. https://doi.org/10.1038/celldisc.2017.7
Totura, A.L. and Baric, R.S. (2012) SARS Coronavirus Pathogenesis: Host Innate Immune Responses and Viral Antagonism of Interferon. Current Opinion in Virology, 2, 264-275. https://doi.org/10.1016/j.coviro.2012.04.004
Cervantes-Barragan, L., Züst, R., Weber, F., Spiegel, M., Lang, K. S., Akira, S., Thiel, V. and Ludewig, B. (2007) Control of Coronavirus Infection through Plasmacytoid Dendritic-Cell-Derived Type I Interferon. Blood, 109, 1131-1137. https://doi.org/10.1182/blood-2006-05-023770
Davidson, S., Maini, M.K. and Wack, A. (2015) Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections. Journal of Interferon & Cytokine Research, 35, 252-264. https://doi.org/10.1089/jir.2014.0227
Newton, A.H., Cardani, A. and Braciale, T.J. (2016) The Host Immune Response in Respiratory Virus Infection: Balancing Virus Clearance and Immunopathology. Seminars in Immunopathology, 38, 471-482. https://doi.org/10.1007/s00281-016-0558-0
Keam, S., Megawati, D., Patel, S.K., Tiwari, R., Dhama, K. and Harapan, H. (2020) Immunopathology and Immunotherapeutic Strategies in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Reviews in Medical Virology, 30, e2123. https://doi.org/10.1002/rmv.2123
Kikkert, M. (2020) Innate Immune Evasion by Human Respiratory RNA Viruses. Journal of Innate Immunity, 12, 4-20. https://doi.org/10.1159/000503030
Li, X., Geng, M., Peng, Y., Meng, L. and Lu, S. (2020) Molecular Immune Pathogenesis and Diagnosis of COVID-19. Journal of Pharmaceutical Analysis, 10, 102-108. https://doi.org/10.1016/j.jpha.2020.03.001
Dhama, K., Sharun, K., Tiwari, R., Dadar, M., Malik, Y.S., Singh, K.P. and Chaicumpa, W. (2020) COVID-19, An Emerging Coronavirus Infection: Advances and Prospects in Designing and Developing Vaccines, Immunotherapeutics, and Therapeutics. Human Vaccines & Immunotherapeutics, 16, 1232-1238. https://doi.org/10.1080/21645515.2020.1735227
Casadevall, A. and Pirofski, L. (2020) The Convalescent Sera Option for Containing COVID-19. Journal of Clinical Investigation, 130, 1545-1548. https://doi.org/10.1172/JCI138003
Liu, L., Wang, P., Nair, M.S., Yu, J., Rapp, M., Wang, Q., et al. (7821) Potent Neutralizing Antibodies against Multiple Epitopes on SARS-CoV-2 Spike. Nature, 584, 450-456. https://doi.org/10.1038/s41586-020-2571-7
Wec, A.Z., Wrapp, D., Herbert, A.S., Maurer, D.P., Haslwanter, D., Sakharkar, M., et al. (2020) Broad Neutralization of SARS-Related Viruses by Human Monoclonal Antibodies. Science, 369, 731-736. https://doi.org/10.1126/science.abc7424
Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J.C., et al. (2020) Escape from Neutralizing Antibodies by SARSCoV-2 Spike Protein Variants. eLife, 9, e61312. https://doi.org/10.7554/eLife.61312
Felgenhauer, U., Schoen, A., Gad, H.H., Hartmann, R., Schaubmar, A.R., Failing, K., Drosten, C. and Weber, F. (2020) Inhibition of SARS-CoV-2 by Type I and Type III Interferons. Journal of Biological Chemistry, 295, 13958-13964. https://doi.org/10.1074/jbc.AC120.013788
Falzarano, D., De Wit, E., Martellaro, C., Callison, J., Munster, V.J. and Feldmann, H. (2013) Inhibition of Novel β Coronavirus Replication by a Combination of Interferon-α2b and Ribavirin. Scientific Reports, 3, Article No. 1686. https://doi.org/10.1038/srep01686
Zielecki, F., Weber, M., Eickmann, M., Spiegelberg, L., Zaki, A.M., Matrosovich, M., Becker, S. and Weber, F. (2013) Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus. Journal of Virology, 87, 5300-5304. https://doi.org/10.1128/JVI.03496-12
Anders, K.L., Indriani, C., Ahmad, R.A., Tantowijoyo, W., Arguni, E., Andari, B., Jewell, N.P., et al. (2018) The AWED Trial (Applying Wolbachia to Eliminate Dengue) to Assess the Efficacy of Wolbachia-Infected Mosquito Deployments to Reduce Dengue Incidence in Yogyakarta, Indonesia: Study Protocol for a Cluster Randomised Controlled Trial. Trials, 19, Article No. 302. https://doi.org/10.1186/s13063-018-2670-z
Wang, Z., Yang, B., Li, Q., Wen, L. and Zhang, R. (2020) Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clinical Infectious Diseases, 71, 769-777. https://doi.org/10.1093/cid/ciaa272
Jodele, S. and Köhl, J. (2020) Tackling COVID-19 Infection through Complement-Targeted Immunotherapy. British Journal of Pharmacology, 178, 2832-2848. https://doi.org/10.22541/au.158880110.01220133
Zhang, Q., Wang, Y., Qi, C., Shen, L. and Li, J. (2020) Clinical Trial Analysis of 2019-nCoV Therapy Registered in China. Journal of Medical Virology, 92, 540-545. https://doi.org/10.1002/jmv.25733
Levine, M.M. (2019) Monoclonal Antibody Therapy for Ebola Virus Disease. The New England Journal of Medicine, 381, 2365-2366. https://doi.org/10.1056/NEJMe1915350
Di Gioacchino, M., Petrarca, C., Gatta, A., Scarano, G., Farinelli, A., Della Valle, L., Lumaca, A., Del Biondo, P., Paganelli, R. and Di Giampaolo, L. (2020) Nanoparticle-Based Immunotherapy: State of the Art and Future Perspectives. Expert Review of Clinical Immunology, 16, 513-525. https://doi.org/10.1080/1744666X.2020.1762572
Shi, Y. and Lammers, T. (2019) Combining Nanomedicine and Immunotherapy. Accounts of Chemical Research, 52, 1543-1554. https://doi.org/10.1021/acs.accounts.9b00148
Irvine, D.J., Hanson, M.C., Rakhra, K. and Tokatlian, T. (2015) Synthetic Nanoparticles for Vaccines and Immunotherapy. Chemical Reviews, 115, 11109-11146. https://doi.org/10.1021/acs.chemrev.5b00109
Moyer, T.J., Zmolek, A.C. and Irvine, D.J. (2016) Beyond Antigens and Adjuvants: Formulating Future Vaccines. Journal of Clinical Investigation, 126, 799-808. https://doi.org/10.1172/JCI81083
Mostafavi, M., Alizadeh, M., Shaabani, M. and Asadi, H. (2021) Metallic Nanomaterials in Cancer Theranostics: A Review of Iron Oxide and Gold-Based Nanomaterials. Journal of Nanotechnology & Material Science, 3, 564.
Kim, S.-H. and Jang, Y.-S. (2017) The Development of Mucosal Vaccines for Both Mucosal and Systemic Immune Induction and the Roles Played by Adjuvants. Clinical and Experimental Vaccine Research, 6, 15-21. https://doi.org/10.7774/cevr.2017.6.1.15
Liu, M.A. (2019) A Comparison of Plasmid DNA and MRNA as Vaccine Technologies. Vaccines, 7, Article 37. https://doi.org/10.3390/vaccines7020037
Afrough, B., Dowall, S. and Hewson, R. (2019) Emerging Viruses and Current Strategies for Vaccine Intervention. Clinical and Experimental Immunology, 196, 157-166. https://doi.org/10.1111/cei.13295
Zaman, M., Good, M.F. and Toth, I. (2013) Nanovaccines and Their Mode of Action. Methods, 60, 226-231. https://doi.org/10.1016/j.ymeth.2013.04.014
Ghanavi, J., Mostafavi, M. and Ghanavi, Z. (2016) Method for the Synthesis of Metallic Nano Products. United States Patent No. US 9,487,399.
Jalaledin, G. and Mehrnaz, M. (2011) Method for Producing Rod-Shaped and Branched Metallic Nano-Structures by Polyol Compounds. United States Patent Application No. US 12/870,792.
Savareh, A., Bashiri, B.A. and Mostafavi, M. (2017) Neighborhood Matrix: A New Idea in Matching of Two Dimensional Gel Images. Progress in Biological Sciences, 6, 129-137.
Mostafavi, M., Alizadeh, M., Shaabani, M. and Ahad Baqeri, S. (2018) Engineering Plasmonic Nanostructures with Combining Ultrasound and Laser Pulses. Health Biotechnology and Biopharma, 2, 49-55.
Mostafavi, M. and Ghanavi, J. (2012) Nanotechnology in Proteomics: Current Status, Promises and Challenges. Journal of Paramedical Sciences, 3.
Mostafavi, M., Ghanavi, J., Shaabani, M., Asadi, H. and Alizadeh, M. (2021) Application of Semiconductor Nanomaterials in Cancer Theranostics. Journal of Nanomedicine & Nanotechnology, 12, Article No. 563. https://www.walshmedicalmedia.com/open-access/application-of-semiconductor-nanomaterials-in-cancer-theranostics.pdf